Skip to content
Government VIC, Medical Health Aged Care

Five VicHealth former chairs urge government retain the health promotion foundation

Public Health Association of Australia 2 mins read

Open letter to the Victorian Premier, Treasurer, and Health Minister

 

(Issued by the Public Health Association of Australia on the authors' behalf).

 

8 December 2025

 

As five former Chairs of VicHealth, representing a broad political spectrum and different eras of VicHealth’s work, we write to ask you to reconsider your Government’s decision to abolish VicHealth and place its important preventative health functions in the Health Department. We believe the decision is misguided and will fail to deliver the hoped-for savings. 

 

Abolishing VicHealth will severely reduce the effectiveness of important and innovative public health work in this State. Even with the best intentions, we fear a large and busy Health Department responsible for acute care will always struggle to prioritise prevention and health promotion. This work is best done by an independent agency. VicHealth’s strength has been close relationships developed with communities (where governments are unable to form partnerships directly) and it’s therefore vital that we save its internationally-respected programs. 

 

You may be surprised by the breadth and depth of support for VicHealth, as it has worked so closely with health, sporting, art and multicultural organisations across the state over many decades. 

 

We respect that the government needs to manage its finances - but a small saving from abolishing VicHealth will create bigger costs into the future. The latest figures from the Federal Government show the value of every dollar spent on health prevention returns over $14.  

 

The legislation establishing VicHealth way back in 1987 deliberately included 3 members of Parliament on the board to ensure long term, multi-party support for a new Victorian institution.  It was envisioned to extend beyond the life of the government of the day, or financial pressures of the moment, and has done so with distinction for nearly 4 decades. We have all witnessed it successes first-hand.

 

Please urgently re-consider this course of action and keep an important institution alive for current and future generations of Victorians.

 

Yours sincerely,

 

Former Chairs of Vic Health (Victorian Health Promotion Foundation)

The Hon Nicola Roxon, Former Commonwealth Labor Minister

The Hon Mark Birrell AM, Former State Liberal Minister 

Fiona McCormack AM, Former CEO of Domestic Violence Victoria, Former Victims of Crime Commissioner

Jane Fenton AM, businesswoman, Former CEO of Fenton Communications

Nick Green OAM, Olympic Gold medallist, sports administrator 

 

 


Contact details:

For comment/interview:
Paris Lord (he/him), Communications and Media Manager, 0478 587 917

[email protected]

More from this category

  • Medical Health Aged Care, Research Development
  • 13/01/2026
  • 14:06
Centre for Healthy Brain Ageing (CHeBA), UNSW Sydney

Simple tool predicts who is most at risk of dementia after stroke

A new international study led by researchers from UNSW Sydney’s Centre for Healthy Brain Ageing (CHeBA) has developed the first practical, five-year dementia risk…

  • Contains:
  • Business Company News, Medical Health Aged Care
  • 13/01/2026
  • 10:50
Nova Eye Medical (ASX:EYE)

Nova Eye Medical Reports Record Sales Result for December 2025 Quarter

HIGHLIGHTS Record December quarter with global sales of US$6.1 million, up 38% on pcp and 25% on the September 2025 quarter Global six-month sales…

  • Contains:
  • Finance Investment, Medical Health Aged Care
  • 13/01/2026
  • 10:09
Jane Morgan Management

NeuroScientific Biopharmaceuticals (ASX:NSB) Reports Clinical Response for StemSmart(TM) Treatment in Fistulising Crohn’s Disease Under Special Access Program

13 January 2026 – Perth, Australia | NeuroScientific Biopharmaceuticals Limited (ASX:NSB) has today announced a “Clinical Response” from patients treated with its patented StemSmart™ Mesenchymal Stem Cell (MSC) therapy under the Therapeutic Goods Administration’s (TGA) Special Access Scheme (SAS) for fistulising Crohn’s disease. Three of four patients treated in Cohort 1 of the Special Access Program demonstrated a successful “Clinical Response” following treatment with StemSmart™, with the fourth patient showing a partial response with further clinical assessment needed. A Clinical Response is defined as either closure of at least 50 per cent of fistula openings or a reduction in fistula…

  • Contains:

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.